Virtu Financial LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 201 filers reported holding REATA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.6%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$682,000
+96.0%
20,815
+746.5%
0.05%
+47.1%
Q2 2021$348,000
-69.8%
2,459
-56.4%
0.03%
-69.6%
Q4 2019$1,152,000
+102.5%
5,634
-20.5%
0.11%
+154.5%
Q3 2019$569,000
+1.1%
7,085
+7.5%
0.04%
+37.5%
Q1 2019$563,0006,5910.03%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders